Besifloxacin Ophthalmic Suspension: Emerging Evidence of its Therapeutic Value in Bacterial Conjunctivitis

OBJECTIVE: To outline the pharmacodynamics, efficacy and safety of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis. QUALITY OF EVIDENCE: MEDLINE database was searched to review recent pharmacodynamic and clinical studies evaluating besifloxacin and comparing besi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Khimdas, S., Visscher, K.L., Hutnik, C.M.L.
Médium: Artigo
Jazyk:Inglês
Vydáno: Libertas Academica 2011
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3661456/
https://ncbi.nlm.nih.gov/pubmed/23861618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/OED.S4102
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky